- Estimated deadline
- No fixed deadline
- Expected posting
- Aug 14, 2024
- Award size
- $650K to $900K
- Total program funding
- Not listed
- Expected awards
- Not listed
- Cost sharing
- Not required
- Funding type
- Grant
- Category
- Consumer protection, Food and nutrition, Agriculture
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.
Who can apply
- Special district governments
- Nonprofits with 501(c)(3) status
- Public and state universities
- Public and Indian housing authorities
- Anyone (unrestricted)
- Independent school districts
- Other Native American tribal organizations
- State governments
- Small businesses
- Federally recognized tribal governments
- City or township governments
- Private universities
- Nonprofits without 501(c)(3) status
- County governments
- For-profit organizations
See the official notice for eligibility details.
Agency contact
Terrin Brown
Grantor
2404027610
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from FDA
All FDA funding- OpenPAR-24-216
Minor Use Minor Species Development of Drugs (R01)
Deadline Jan 29, 2027Up to $250K
- OpenPAR-25-003
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Deadline Apr 1, 2027Up to $300K
- OpenPAR-25-014
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Deadline Apr 1, 2027Up to $200K
- OpenRFA-FD-25-007
Laboratory Flexible Funding Model (LFFM)
Deadline Jan 11, 2028Up to $1.5M
- OpenRFA-FD-25-017
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Deadline Feb 8, 2028Up to $600K
- OpenPAR-24-251
Animal and Veterinary Innovation Centers (U18)
Deadline May 12, 2028Up to $1.3M
Get new funding every Monday
New federal opportunities and upcoming deadlines for FDA and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Mar 26, 2026. Deadlines and requirements can change: always confirm them in the official notice.